Clinical trial
A Phase II, Multicenter Clinical Study of Oral Paclitaxel Solution as Neoadjuvant Therapy in Elderly Patients With Non-Small Cell Lung Cancer
NCT07599163 is registered in ClinicalTrials.gov with Shanghai Pulmonary Hospital, Shanghai, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Multicenter Clinical Study of Oral Paclitaxel Solution as Neoadjuvant Therapy in Elderly Patients With Non-Small Cell Lung Cancer
- Lead sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 8, 2026
- Completion date
- December 30, 2030
- Enrollment
- 75 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
neoadjuvant therapy, non-small-cell lung cancer, paclitaxel